Plaque protrusion in carotid artery stenting: what are its risks and how can we prevent them?

Courtesy of Dr. Carlos Fava.

Plaque Protrusion in Carotid Artery Stenting: What Are Its Risks and How Can We Prevent Them?Carotid artery stenting (CAS) has proven to be effective in high-risk patients. Nowadays, when performed by trained operators, its results are similar to those of surgery. This study seeks to clarify the incidence and prognosis of plaque protrusion through the stent (as observed in both control angiography and intravascular ultrasound [IVUS]) during carotid artery stenting.

 

A total of 354 carotid atherosclerotic stenoses in 328 consecutive patients who underwent stenting were retrospectively analyzed. Plaque protrusion was defined as plaque inside the stent lumen after dilatation, as observed through both digital subtraction angiography and IVUS. The incidence of ischemic stroke within 30 post-operative days and the presence of ischemic lesions as observed through diffusion-weighted nuclear magnetic resonance imaging performed within 48 post-operative hours were analyzed.

 

Plaque protrusion was observed in 9 patients (2.6%). The mean age was 73 years old (most patients were male) and 80% of patients presented carotid artery lesions. No difference was observed regarding protection system or stent type used. All patients received dual antiplatelet therapy.

 

The presence of plaque protrusion was significantly higher in patients who received open-cell stents. At 30 days, the incidence of stroke was higher in the plaque protrusion patient group (66.6% vs.1.1%; p = < 0.0001). At 48 hours, lesions were observed through diffusion-weighted imaging in more patients (8) in this group than in those who received open-cell stents and presented unstable plaque.

 

Plaque protrusion was strongly associated with peri-procedural stroke.

 

Conclusion

The incidence of plaque protrusion in carotid artery stenting was 2.6% and it was associated with a high risk of ischemic complications. These findings indicate the necessity of appropriate device selection to avoid plaque protrusion.

 

Editorial Comment

While operator expertise has lowered the rates of adverse events, current technology must be improved in order to avoid plaque protrusion, which is associated with an extremely high rate of stroke.

 

This undesired event does not only affect the patient: it alters his/her family and social relationships, and it creates high costs for health systems.

 

Courtesy of Dr. Carlos Fava.

 

Original title: Carotid Artery Stenting. Investigation of Plaque Protrusion Incidence and Prognosis.

Reference: Masashi Kotsugi, et al. J Am Coll Cardiol Intv 2017;10:824-31.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...